These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33124454)

  • 21. Lasers in the era of evidence-based medicine.
    Hillard TC
    Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CO
    Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
    Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
    Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
    Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.
    Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z
    Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness.
    Peker H; Gursoy A
    J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Er:YAG Laser for Women with Stress Urinary Incontinence.
    Lin KL; Chou SH; Long CY
    Biomed Res Int; 2019; 2019():7915813. PubMed ID: 30766886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.
    Mounir DM; Hernandez N; Gonzalez RR
    Urology; 2021 May; 151():2-7. PubMed ID: 32966821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
    Gaspar A; Brandi H; Gomez V; Luque D
    Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of fractional CO
    Quick AM; Dockter T; Le-Rademacher J; Salani R; Hudson C; Hundley A; Terstriep S; Streicher L; Faubion S; Loprinzi CL; Coleman JS; Wang KC; Lustberg M
    Maturitas; 2021 Feb; 144():37-44. PubMed ID: 33358206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary outcome of non-ablative vaginal Erbium laser treatment for female stress and mixed urinary incontinence.
    Su CF; Chen GD; Tsai HJ
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):610-613. PubMed ID: 31542080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction.
    Lin HY; Tsai HW; Tsui KH; An YF; Lo CC; Lin ZH; Liou WS; Wang PH
    Taiwan J Obstet Gynecol; 2018 Dec; 57(6):825-829. PubMed ID: 30545535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erbium laser in gynecology: aims, aspirations and action points.
    Gambacciani M; Cervigni M
    Climacteric; 2015; 18 Suppl 1():2-3. PubMed ID: 26366792
    [No Abstract]   [Full Text] [Related]  

  • 36. Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype?
    Tranoulis A; Georgiou D; Michala L
    Int Urogynecol J; 2019 Nov; 30(11):1879-1886. PubMed ID: 31321465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The VELA experience: a strategic format.
    Grassiri G; Cervigni M; Bracco GL; Gambacciani M;
    Climacteric; 2020; 23(sup1):S4-S5. PubMed ID: 33124453
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
    Sokol ER; Karram MM
    Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No. 358-Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence.
    Walter JE; Larochelle A
    J Obstet Gynaecol Can; 2018 Apr; 40(4):503-511. PubMed ID: 29680080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.